Related references
Note: Only part of the references are listed.Pharmacologic cholinesterase inhibition improves survival in experimental sepsis
Stefan Hofer et al.
CRITICAL CARE MEDICINE (2008)
Systemic inflammatory response syndrome increases immobility-induced neuromuscular weakness
Heidrun Fink et al.
CRITICAL CARE MEDICINE (2008)
Chronic Escherichia coli infection induces muscle wasting without changing acetylcholine receptor numbers
Christiane G. Frick et al.
INTENSIVE CARE MEDICINE (2008)
Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm muscle function
Matthias Eikermann et al.
ANESTHESIOLOGY (2007)
Succinylcholine-induced hyperkalemia in acquired pathologic states - Etiologic factors and molecular mechanisms
JAJ Martyn et al.
ANESTHESIOLOGY (2006)
Neuromuscular manifestations of critical illness
CF Bolton
MUSCLE & NERVE (2005)
Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness
SN Fletcher et al.
CRITICAL CARE MEDICINE (2003)
Creatine phosphate kinase elevations signaling muscle damage following exposures to anticholinesterases: 2 sentinel patients
LS Friedman et al.
ARCHIVES OF ENVIRONMENTAL HEALTH (2003)
Systemic inflammation leads to resistance to atracurium without increasing membrane expression of acetylcholine receptors
H Fink et al.
ANESTHESIOLOGY (2003)
Paresis acquired in the intensive care unit -: A prospective multicenter study
B De Jonghe et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Advances in neurobiology of the neuromuscular junction - Implications for the anesthesiologist
M Naguib et al.
ANESTHESIOLOGY (2002)
Risk factors for the development of polyneuropathy and myopathy in critically ill patients
MACJ de Letter et al.
CRITICAL CARE MEDICINE (2001)
Share Paper
